Our achievements • In the press
August 2020 • 1 Min Read
Cambridge, United Kingdom – 24 August 2020, perfeXia Health Technologies Ltd, an innovative HealthTech start-up founded in Cambridge UK, has been accepted to the Accelerate Cambridge Programme- a start-up accelerator established by Cambridge Judge Business School in May 2012. perfeXia previously took part in the EnterpriseTECH programme at Cambridge Judge .
Powered by its proprietary DeepTech, perfeXia is invested in developing a preventative healthcare remote diagnostic and monitoring system. With much NHS resource going to fight coronavirus, other treatments are delayed and labs are busy with COVID-19 tests, so “to ensure that people can still access important medical services, a tool is needed to remotely monitor patient health,” perfeXia's research team says.
The flagship product, DocMe is a digital HealthTech that puts healthcare in the hands of individuals. DocMe is a digital HealthTech platform that empowers people to look after their health. Using Computer Vision, Explainable AI and Edge Machine Learning, the app can extract clinically-relevant vital signs viz. heart rate, oxygen saturation, and respiratory rate with patients taking a 30-second video selfie. DocMe helps doctors connect remotely with patients and conduct groundbreaking medical research. The result is care that becomes more efficient and more personalised.
" Seasoned coaches and industry experts at Accelerate Cambridge Programme will be essential to the further development of our technology and its regulatory approval. It is the expertise and investment of the programme that will help us to create the next generation HealthTech towards broadening access to healthcare, and I cannot thank them enough for selecting our us", said Pratyay Poddar, founder and CEO of perfeXia HealthTech.
Read more about DocMe at: